Multivariate Analysis of Predictors of Seropositivity Among Patients Aged 6–9 Months by Demographic or Other Attributes Kano State, Northern Nigeria, 2015
| . | Type 1 . | Type 2 . | Type 3 . | ||||
|---|---|---|---|---|---|---|---|
| Covariate . | Comparison . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . |
| Father’s education | Secondary/Tertiary vs primary or less | 2.76 (1.07–7.15) | .035 | NA | NA | NA | NA |
| Stunting | Moderate and severe vs no stunting | 0.44 (0.13–1.47) | .173 | NA | NA | 0.27 (0.08–0.89) | .034 |
| Routine immunization | Each additional dose | 1.51 (1.16–1.99) | .003 | 2.35 (1.67–3.54) | <.001 | 1.71 (1.32–2.27) | <.001 |
| SIA | 1+ vs 0 SIA doses | 2.46 (0.71–8.37) | .147 | 11.54 (2.69–59.13) | .001 | 4.38 (1.31–15.6) | .018 |
| . | Type 1 . | Type 2 . | Type 3 . | ||||
|---|---|---|---|---|---|---|---|
| Covariate . | Comparison . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . |
| Father’s education | Secondary/Tertiary vs primary or less | 2.76 (1.07–7.15) | .035 | NA | NA | NA | NA |
| Stunting | Moderate and severe vs no stunting | 0.44 (0.13–1.47) | .173 | NA | NA | 0.27 (0.08–0.89) | .034 |
| Routine immunization | Each additional dose | 1.51 (1.16–1.99) | .003 | 2.35 (1.67–3.54) | <.001 | 1.71 (1.32–2.27) | <.001 |
| SIA | 1+ vs 0 SIA doses | 2.46 (0.71–8.37) | .147 | 11.54 (2.69–59.13) | .001 | 4.38 (1.31–15.6) | .018 |
P value indicates significance based on best-fitting model for each poliovirus serotype. .
Abbreviations: CI, confidence interval; NA, not included in final model based on Akaike information criterion; OR, odds ratio; SIA, supplementary immunization activity.
Multivariate Analysis of Predictors of Seropositivity Among Patients Aged 6–9 Months by Demographic or Other Attributes Kano State, Northern Nigeria, 2015
| . | Type 1 . | Type 2 . | Type 3 . | ||||
|---|---|---|---|---|---|---|---|
| Covariate . | Comparison . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . |
| Father’s education | Secondary/Tertiary vs primary or less | 2.76 (1.07–7.15) | .035 | NA | NA | NA | NA |
| Stunting | Moderate and severe vs no stunting | 0.44 (0.13–1.47) | .173 | NA | NA | 0.27 (0.08–0.89) | .034 |
| Routine immunization | Each additional dose | 1.51 (1.16–1.99) | .003 | 2.35 (1.67–3.54) | <.001 | 1.71 (1.32–2.27) | <.001 |
| SIA | 1+ vs 0 SIA doses | 2.46 (0.71–8.37) | .147 | 11.54 (2.69–59.13) | .001 | 4.38 (1.31–15.6) | .018 |
| . | Type 1 . | Type 2 . | Type 3 . | ||||
|---|---|---|---|---|---|---|---|
| Covariate . | Comparison . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . | OR (95% CI) . | P Value . |
| Father’s education | Secondary/Tertiary vs primary or less | 2.76 (1.07–7.15) | .035 | NA | NA | NA | NA |
| Stunting | Moderate and severe vs no stunting | 0.44 (0.13–1.47) | .173 | NA | NA | 0.27 (0.08–0.89) | .034 |
| Routine immunization | Each additional dose | 1.51 (1.16–1.99) | .003 | 2.35 (1.67–3.54) | <.001 | 1.71 (1.32–2.27) | <.001 |
| SIA | 1+ vs 0 SIA doses | 2.46 (0.71–8.37) | .147 | 11.54 (2.69–59.13) | .001 | 4.38 (1.31–15.6) | .018 |
P value indicates significance based on best-fitting model for each poliovirus serotype. .
Abbreviations: CI, confidence interval; NA, not included in final model based on Akaike information criterion; OR, odds ratio; SIA, supplementary immunization activity.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
